nuclivision’s Post

BIG NEWS: nuclivision has raised 5 million euros 💥💥💥 We’re proud to announce the closing of our €5M seed round with HERAN Partners, LUMO Labs, and imec.istart future fund. Their trust, expertise, and capital will enable us to accelerate the commercialization of our PET image enhancement software, Nuclarity, across Europe and the US. This milestone also strengthens our commitment to continued innovation in the promising & growing field of nuclear medicine—driven by rising oncology volumes, radiotracer innovations, and the rise of theranostics. As one of the few software-first players, we’re uniquely positioned to make nuclear medicine safer, more affordable, and more accessible. Obviously we can’t scale Nuclivision alone. We're currently hiring for roles including Head of Growth, Marketing Specialist, Cloud Engineer, and more to come. Explore opportunities on our careers page—link in the comments. 💼🔍👩💻 A sincere thank you to our advisory board for their always-invaluable input, to our early believers imec.istart and LUMIARES, and to Liedekerke & Mace for their legal guidance during this round. Super excited for what’s coming, get in touch if you are too! 🛡️☢️💡🌍 Herman Verrelst, Thomas Hannes, Kris Vandenberk, Roland Hustinx, Prof. Nikos Paragios, Filip Vandamme, Ilse Vanhulle, Geoffrey D'hondt, Pim Hollestelle, Ruth Janssens, Laurens de Vries, MD, Jean-Briac Prevost, Sezgin Üstmert, Stefaan Vandenberghe, Gregor Strobbe